Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02406508
Title Sequential Melphalan for Use With Hepatic Delivery System Treatment Followed by Sorafenib in Patients With Unresectable HCC
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Delcath Systems Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.